SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024997
Filing Date
2021-05-06
Accepted
2021-05-06 16:18:17
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q oric-10q_20210331.htm   iXBRL 10-Q 2193979
2 EX-31.1 oric-ex311_26.htm EX-31.1 20118
3 EX-31.2 oric-ex312_27.htm EX-31.2 20248
4 EX-32.1 oric-ex321_28.htm EX-32.1 9542
5 EX-32.2 oric-ex322_29.htm EX-32.2 9528
  Complete submission text file 0001564590-21-024997.txt   6069308

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA oric-20210331.xsd EX-101.SCH 36935
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oric-20210331_cal.xml EX-101.CAL 35861
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oric-20210331_def.xml EX-101.DEF 105358
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oric-20210331_lab.xml EX-101.LAB 306948
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oric-20210331_pre.xml EX-101.PRE 221386
11 EXTRACTED XBRL INSTANCE DOCUMENT oric-10q_20210331_htm.xml XML 862368
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39269 | Film No.: 21898053
SIC: 2834 Pharmaceutical Preparations